The Diverse Roles of Microorganisms in Biomedicine, Industry, and the Environment: A Study of Algae, Bacteria, Fungi, and Viruses
微生物の生物医学、産業、環境における多様な役割：藻類、細菌、真菌、ウイルスの研究 (AI 翻訳)
P. Thirupathi
🤖 gxceed AI 要約
日本語
本論文は、微生物（藻類、細菌、真菌、ウイルス）が医療、産業、環境分野で果たす役割を体系的にレビューする。遺伝子治療やバクテリオファージ療法、循環型バイオ経済のための発酵プロセス、PFASのバイオレメディエーション、微生物炭素固定など最新の進展をまとめ、微生物技術の急速な拡大と将来の展望を示す。
English
This paper systematically reviews the evolving roles of microorganisms (algae, bacteria, fungi, viruses) in biomedicine, industry, and the environment. It covers recent advances in viral vectors for gene therapy, bacteriophage therapy for MDR bacteria, fermentation for biodegradable plastics, and microbial carbon capture and PFAS bioremediation, highlighting the rapid scaling of microbial technology.
Unofficial AI-generated summary based on the public title and abstract. Not an official translation.
📝 gxceed 編集解説 — Why this matters
日本のGX文脈において
本論文はGX（グリーントランスフォーメーション）に直接関連するものではないが、微生物を用いた炭素固定や有害物質の分解技術は日本の環境政策や産業応用の可能性を示唆する。ただし、気候関連開示やエネルギー転換の議論には直接結びつかない。
In the global GX context
While not directly about climate disclosure or decarbonization, the paper reviews microbial carbon capture and bioremediation technologies that could inform Nature-based Solutions (NbS) and circular economy strategies. These are peripheral to mainstream GX frameworks like TCFD or ISSB.
👥 読者別の含意
🔬研究者:Microbiologists and biotechnologists will find a broad overview of 2024-2025 microbial innovations across sectors.
🏢実務担当者:Industrial biotech or environmental remediation firms may gain insights into scalable microbial processes for PHAs or PFAS treatment.
📄 Abstract（原文）
Microorganisms, encompassing algae, bacteria, fungi, and viruses, are no longer viewed merely as agents of disease but as indispensable biological factories driving innovation in the 21st century. This study systematically examines the evolving roles of these microbes across biomedical, industrial, and environmental sectors. In biomedicine, the focus has shifted toward precision medicine, with 2024–2025 research highlighting the success of viral vectors in gene therapy and the resurgence of bacteriophage therapy to combat multi-drug resistant (MDR) bacteria. Industrial applications have transitioned toward a "circular bioeconomy", where fungal and bacterial fermentation processes are used to produce biodegradable polyhydroxyalkanoates (PHAs) and high-value enzymes for the food and biofuel sectors. Environmental efforts are now centered on microbial carbon capture and advanced bioremediation of "forever chemicals" (PFAS). This article synthesizes recent data, including the 2024 Global Bio-India findings and 2025 advances in microbial mineral carbonation, to outline a roadmap for future microbial exploration and demonstrates that the integration of algae, bacteria, fungi, and viruses is not merely an academic exercise but a necessity for surviving the ecological and health challenges of the late 2020s. The data from 2024 and 2025 confirm that microbial technology is scaling rapidly, offering a path to a future where medicine is personalized, industry is circular, and the environment is actively restored.
🔗 Provenance — このレコードを発見したソース
- semanticscholar https://doi.org/10.71097/ijsat.alsdahw-2025.116first seen 2026-05-06 00:05:25
🔔 こうした論文の新着を逃したくない方は キーワードアラート に登録（無料・3キーワードまで）。
gxceed は公開メタデータに基づく研究支援データセットです。要約・翻訳・解説は AI 支援で生成されています。 最終的な解釈・検証は利用者が原典資料に基づいて行うことを前提とします。